Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to concerns of increased risk of bleeding complications.

Leave A Comment

Your email address will not be published. Required fields are marked *